Mosong, Molly M.

HRN: 16-15-79  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/29/2022
CEFTRIAXONE 1G (VIAL)
11/29/2022
12/05/2022
IV
2g
Q24H
Community Acquired Pneumonia - Moderate Risk
Waiting Final Action 
11/29/2022
AZITHROMYCIN 500MG TABLET (TAB)
11/29/2022
12/03/2022
ORAL
500 Mg
Q24H
Community Acquired Pneumonia - Moderate Risk
Waiting Final Action 
12/07/2022
CEFIXIME 200MG (CAP)
12/07/2022
12/14/2022
PO
200mg
BID
CAP MR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: